How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Close this folder5 ADDITIONAL SOURCES OF INFORMATION
View the documentThe evidence-based approach in formulary development
View the documentInformation retrieval
Open this folder and view contentsTypes of source
Open this folder and view contentsSearching for the best evidence
Open this folder and view contentsAccessibility
View the documentCritical appraisal
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

The evidence-based approach in formulary development

Any new information included in the NF should promote the rational and evidence-based use of medicines. Evidence-based drug therapy means integrating the best, currently available clinical evidence from scientific research with the individual clinical expertise of the prescriber to improve patient care. Informing prescribers about current evidence-based practices and national guidelines can help close the gap between research findings and their implementation in routine practice. Therefore a NF presenting such up-to-date information can be a valuable educational tool in the promotion of evidence-based drug therapy.

When trying to fill gaps in the drug and therapeutics information included in the NF, there are three important questions that need to be answered.

• Where do we find the information?
• Is this the most up-to-date and valid information?
• How relevant and applicable is this information to our local conditions?


Answering these questions requires good information retrieval and critical appraisal skills. The editors and the NFC can be assisted with both of these tasks by experienced health information specialists, such as medical librarians or personnel from national drug information centres and independent drug bulletins. The Society of Hospital Pharmacists of Australia5 (SHPA) has an international register of drug information services on its web site and the International Society of Drug Bulletins6 (ISDB) also lists contact addresses for independent drug information bulletins around the world.

5 SHPA http://www.shpa.org.au/frame.htm
6 ISDB http://www.isdbweb.org

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014